» Articles » PMID: 23138613

Clinical and Histological Prognostic Factors for Local Recurrence and Metastasis of Cutaneous Squamous Cell Carcinoma: Analysis of a Defined Population

Overview
Specialty Dermatology
Date 2012 Nov 10
PMID 23138613
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous squamous cell carcinomas (cSCC) can recur locally and can metastasize. The objective of this study was to identify clinical and histopathological prognostic factors for local recurrence and metastasis in cSCCs at any body site. Clinical and histopathological data were collected from 224 patients with cSCC. During the median follow-up period of 43 months (range 0-73 months) the cumulative probabilities of recurrence-free survival at 1, 2 and 4 years post-treatment were 98.0%, 96.9% and 94.7%, respectively, and for metastasis-free survival 98.1%, 97.0% and 95.9%, respectively. In univariate survival analyses, predictors for local recurrence were every millimetre increase in tumour diameter and in tumour thickness. Predictors for metastasis this was location on the ear, invasion of deeper structures, no surgical treatment, poor differentiation, every millimetre increase in tumour diameter and in tumour thickness. In multivariate survival analysis, every millimetre increase in both tumour diameter and tumour thickness were independent predictors for local recurrence as well as for metastasis and, therefore, it is important to report these in patients' files. Defining prognostic valuables is important for diagnostic work-up, treatment and follow-up for an individual patient.

Citing Articles

Tumour Recurrence, Depth of Invasion, and Temple Location as Independent Prognostic Parameters of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinomas.

Horakova Z, Starek I, Zapletalova J, Salzman R Int J Clin Pract. 2024; 2024:9960948.

PMID: 38495750 PMC: 10942823. DOI: 10.1155/2024/9960948.


Histological predictors of outcome for cutaneous squamous cell carcinoma in renal transplant patients: A case-control study.

Harvey N, Palmer D, Tucker P, Chakera A, Foster R, Lim W JAAD Int. 2024; 15:51-58.

PMID: 38371661 PMC: 10869928. DOI: 10.1016/j.jdin.2023.11.010.


Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.

Salido-Vallejo R, Escribano-Castillo L, Antonanzas J, Roldan-Cordoba C, Velez A, Aguado-Gil L J Clin Med. 2023; 12(24).

PMID: 38137687 PMC: 10744076. DOI: 10.3390/jcm12247619.


Cancer-Derived Extracellular Vesicles as Biomarkers for Cutaneous Squamous Cell Carcinoma: A Systematic Review.

Lee I, Shen C, Tsai F, Chen C, Ma K Cancers (Basel). 2022; 14(20).

PMID: 36291882 PMC: 9599948. DOI: 10.3390/cancers14205098.


A Metastatic Well-differentiated Squamous Cell Carcinoma in a Patient with an Arteriovenous Fistula.

Nyeko-Lacek M, John H, Leong S, Short E, Elazzabi T, Jessop Z Plast Reconstr Surg Glob Open. 2022; 10(2):e4100.

PMID: 35242488 PMC: 8884526. DOI: 10.1097/GOX.0000000000004100.